Advertisement
Screener

HERCULES CAPITAL, INC. (HTGC) Spending and interest coverage

HERCULES CAPITAL, INC. (HTGC) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months(m)Share-based compensation / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue(m)
Stock-based compensation15.59M USDShare-based Payment Arrangement, Noncash Expense
Operating income(m)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)(m)$15.59M(m)(m)(m)(m)(m)(m)
2026-03-31(m)(m)$15.34M(m)(m)(m)(m)(m)(m)
2025-12-31(m)(m)$14.79M(m)(m)(m)(m)(m)(m)
2025-09-30(m)(m)$14.27M(m)(m)(m)(m)(m)(m)
2025-06-30(m)(m)$13.77M(m)(m)(m)(m)(m)(m)
2025-03-31(m)(m)$13.31M(m)(m)(m)(m)(m)(m)
2024-12-31(m)(m)$12.48M(m)(m)(m)(m)(m)(m)
2024-09-30(m)(m)$12.35M(m)(m)(m)(m)(m)(m)
2024-06-30(m)(m)$12.13M(m)(m)(m)(m)(m)(m)
2024-03-31(m)(m)$11.89M(m)$78.53M(m)(m)(m)Reported
2023-12-31(m)(m)$11.93M(m)$77.47M(m)(m)(m)Reported
2023-09-30(m)(m)$11.35M(m)$75.54M(m)(m)(m)Reported
2023-06-30(m)(m)$10.84M(m)$73.27M(m)(m)(m)Reported
2023-03-31(m)(m)$10.56M(m)$67.81M(m)(m)(m)Reported
2022-12-31(m)(m)$10.83M(m)$62.35M(m)(m)(m)Reported
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31(m)(m)$10.38M(m)$67.52M(m)(m)(m)Reported
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)(m)$8.47M(m)$66.87M(m)(m)(m)Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.